Chemical Dependency Counselor License Pharmacology of Substance Use Questions and Answers — Questions and Answers
Question 1: A client with alcohol use disorder is prescribed disulfiram. The counselor should educate the client that if they consume alcohol, they will likely experience a highly unpleasant reaction. What is the pharmacological mechanism responsible for this effect?
- It enhances the euphoric effects of alcohol, leading to overdose.
- It blocks opioid receptors, reducing the reinforcing properties of alcohol.
- It inhibits the enzyme aldehyde dehydrogenase, causing a toxic buildup of acetaldehyde. (Correct answer)
- It modulates glutamate and GABA neurotransmitter systems to reduce cravings.
Correct answer: It inhibits the enzyme aldehyde dehydrogenase, causing a toxic buildup of acetaldehyde.
Disulfiram works by irreversibly inhibiting aldehyde dehydrogenase, a key enzyme in the metabolism of alcohol. This blockage leads to the accumulation of acetaldehyde, a toxic byproduct, when alcohol is consumed. The resulting high levels of acetaldehyde cause a severe and unpleasant reaction, including nausea, vomiting, flushing, and palpitations, which serves as a deterrent to drinking.
Question 2: A client is being treated for opioid use disorder with buprenorphine. Which of the following statements BEST describes the primary action of this medication?
- It is a full opioid agonist that completely activates opioid receptors, similar to methadone.
- It is a partial opioid agonist that binds to opioid receptors but produces a less potent effect and has a 'ceiling effect'. (Correct answer)
- It is an opioid antagonist that completely blocks the effects of all opioids at the receptor site.
- It is a non-opioid medication that works by reducing anxiety and insomnia associated with withdrawal.
Correct answer: It is a partial opioid agonist that binds to opioid receptors but produces a less potent effect and has a 'ceiling effect'.
Buprenorphine is a partial opioid agonist. This means it binds to and activates mu-opioid receptors but to a lesser degree than full agonists like methadone or heroin. This partial activation is sufficient to reduce withdrawal symptoms and cravings but has a 'ceiling effect,' meaning its opioid effects plateau at higher doses, which reduces the risk of respiratory depression and overdose compared to full agonists.
Question 3: Naltrexone is an FDA-approved medication for both alcohol use disorder and opioid use disorder. Its mechanism of action involves:
- Creating an aversive reaction to the substance of use.
- Substituting the abused drug with a less potent, longer-acting agonist.
- Blocking the euphoric and reinforcing effects of the substance at the opioid receptor. (Correct answer)
- Restoring the balance between excitatory and inhibitory neurotransmitters in the brain.
Correct answer: Blocking the euphoric and reinforcing effects of the substance at the opioid receptor.
Naltrexone is an opioid receptor antagonist. It works by binding to opioid receptors and blocking them. This action prevents opioids like heroin from binding to the receptors, thereby blocking their euphoric effects. In alcohol use disorder, it is thought to reduce the reinforcing, pleasurable effects of alcohol, which are partially mediated by the endogenous opioid system, thus reducing cravings and the desire to drink.
Question 4: A client who has been taking high doses of a short-acting benzodiazepine for several months decides to stop abruptly. The counselor should be aware that the client is at significant risk for which of the following?
- A mild rebound anxiety and temporary insomnia.
- A severe withdrawal syndrome that can include seizures. (Correct answer)
- An intense but brief period of euphoria followed by a crash.
- A gradual decrease in tolerance with no significant physical symptoms.
Correct answer: A severe withdrawal syndrome that can include seizures.
Abrupt cessation of benzodiazepines, especially short-acting ones taken at high doses, can induce a severe and potentially life-threatening withdrawal syndrome. Symptoms can include intense anxiety, tremors, perceptual disturbances, and, most critically, seizures. Medical supervision and a gradual tapering schedule are essential for safety.
Question 5: Which of the following best explains how stimulant drugs like cocaine and amphetamines produce their intensely reinforcing and euphoric effects?
- They primarily increase the activity of the inhibitory neurotransmitter GABA.
- They block the reuptake of dopamine in the brain's reward pathways, leading to a surplus of dopamine. (Correct answer)
- They mimic the effects of endogenous opioids, leading to pain relief and sedation.
- They cause a severe aversive reaction by inhibiting a key metabolic enzyme.
Correct answer: They block the reuptake of dopamine in the brain's reward pathways, leading to a surplus of dopamine.
The primary mechanism of action for stimulants like cocaine and amphetamines is their effect on the dopamine system. They block the dopamine transporter, which is responsible for removing dopamine from the synapse. This blockage results in a significant increase in the concentration and duration of dopamine in the brain's reward circuits (like the nucleus accumbens), causing intense feelings of pleasure and euphoria.
Question 6: A client with alcohol use disorder is prescribed acamprosate. The primary therapeutic goal of this medication is to:
- Produce a severe physical illness if the client drinks alcohol.
- Block the pleasurable effects of alcohol to extinguish the desire to drink.
- Reduce the uncomfortable symptoms of protracted withdrawal, such as anxiety and restlessness. (Correct answer)
- Act as a substitute for alcohol by providing a similar calming effect.
Correct answer: Reduce the uncomfortable symptoms of protracted withdrawal, such as anxiety and restlessness.
Acamprosate is believed to work by stabilizing the chemical balance in the brain that is disrupted by long-term, heavy alcohol use. Specifically, it helps to modulate the glutamate and GABA neurotransmitter systems. By doing so, it can reduce the prolonged, sub-acute withdrawal symptoms (protracted withdrawal) like insomnia, anxiety, and restlessness that can trigger a relapse and contribute to cravings.
